HCP
70
-4
PNR
74
5
PFG
50
-2
MRO
46
3
BLK
70
-2
STX
52
-4
STI
31
19
EQR
60
6
NOV
58
-2
DG
12
2
T
48
3
SWK
56
-6
GILD
56
-4
EQT
57
-3
ADI
45
-5
EXPE
96
-3
MLM
57
-3
CF
53
2
AVGO
35
-2
CAH
60
2
HCP
70
-4
PNR
74
5
PFG
50
-2
MRO
46
3
BLK
70
-2
STX
52
-4
STI
31
19
EQR
60
6
NOV
58
-2
DG
12
2
T
48
3
SWK
56
-6
GILD
56
-4
EQT
57
-3
ADI
45
-5
EXPE
96
-3
MLM
57
-3
CF
53
2
AVGO
35
-2
CAH
60
2
Financhill
Back

Vanda Pharmaceuticals Quote, Financials, Valuation and Earnings

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Buy
55

VNDA
Vanda Pharmaceuticals

Last Price:
5.10
Seasonality Move:
4.48%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Vanda Pharmaceuticals Price Quote

$5.10
-0.37 (-6.76%)
(Updated: November 14, 2024 at 5:55 PM ET)

Vanda Pharmaceuticals Key Stats

Buy
55
Vanda Pharmaceuticals (VNDA) is a Buy
Day range:
$5.37 - $5.53
52-week range:
$3.32 - $6.75
Dividend yield:
0%
P/E ratio:
135.25
P/S ratio:
1.72
P/B ratio:
0.58%
Volume:
746.8K
Avg. volume:
698K
1-year change:
60.41%
Market cap:
$315.3M
Revenue:
$192.6M
EPS:
$-0.19

How Much Does Vanda Pharmaceuticals Make?

Is Vanda Pharmaceuticals Growing As A Company?

  • What Is Vanda Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.1%
  • What Is Vanda Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Vanda Pharmaceuticals Stock Price Performance

What Is Vanda Pharmaceuticals 52-Week High & Low?

Vanda Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vanda Pharmaceuticals?

Is Vanda Pharmaceuticals Cash Flow Positive?

  • What Is VNDA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$5.1M
  • What Is Vanda Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Vanda Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$41.9M

Vanda Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    VNDA return on invested capital is -2.01%
  • What Is Vanda Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -1.69%
  • What Is VNDA Return On Equity?
    ROE is a measure of profitability and is -2.01%

Vanda Pharmaceuticals Earnings Date & Stock Price

Vanda Pharmaceuticals Competitors

  • Who Are Vanda Pharmaceuticals's Competitors?
    Below is a list of companies who compete with Vanda Pharmaceuticals or are related in some way:
    • Black Diamond Therapeutics Inc (BDTX)
    • Edgewise Therapeutics Inc (EWTX)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Zevra Therapeutics Inc (ZVRA)

Vanda Pharmaceuticals Dividend Yield

Vanda Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 9.59% -3.06%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 10.43
Upside from Last Price: 90.63%

Major Shareholders

  • How many VNDA shares are owned by institutional investors?
    66.6M VNDA shares are owned by institutional investors
  • How many VNDA shares are owned by insiders?
    4M VNDA shares are owned by insiders